Summary
18 male subjects were given 4×2 mg glucagon i.m. per day in cristalline form and 4×4 g of CaCO3 orally for 8 days. A quantitative gastric analysis was performed 12 hours after the last dose of the medication and compared with the results of a gastric analysis carried out at the beginning of the test.
Maximally stimulated H-concentration and H-secretion were significantly reduced by glucagon application. The role of glucagon as a potential therapeutic substance for the reduction of gastric secretion in man is discussed.
Zusammenfassung
18 männliche Probanden erhielten über 8 Tage täglich 4×2 mg kristallines Glucagon i.m. und 4×4 g CaCO3 oral verabreicht. Am Testbeginn und 12 Std nach der letzen Medikamentengabe wurde jeweils eine quantitative Magensekretionsanalyse durchgeführt. Die maximale stimulierte H-Konzentration und H-Sekretion war nach der 8-tägigen Glucagonapplikation signifikant niedriger als davor.
Die Rolle des Glucagons als potentielles Therapeuticum zur Reduktion der gastralen HCl-Sekretion beim Menschen wird diskutiert.
Similar content being viewed by others
Literatur
Avioli, L. V., Birge, S. J., Scott, S., Shieber, W.: Role of the thyroid gland during glucagon induced hypocalcemia in the dog. Amer. J. Physiol.216, 939 (1969).
Barreras, R. F.: Acid secretion after calcium carbonate in patients with doudenal ulcer. New Engl. J. Med.282, 1402 (1970).
Brown, J. C., Magee, F. D.: Inhibitory action of cholecystokinin on acid secretion from Heidenhain pouches induced by endogenous gastrin. Gut8, 29 (1967).
Byrnes, D. J., Young, D., Chisholm, D. J., Lazarus, L.: Serum gastrin in patients with peptic ulceration. Brit. med. J.1970II, 626.
Clarke, S. D., Neill, D. N., Welbourn, L. B.: Effect of glucagon on gastric secretion in the dog. Gut1, 146 (1960).
Cohen, N., Mazure, P., Dreiling, D. A., Janowitz, H. D.: Effect of glucagon on histamine-stimulated gastric secretion in man. Fed. Proc.18, 28 (1959).
Deyhle, P., Nitzsche, R., Miederer, S. E., Ottenjann, R.: Über die Wirkung von Glukagon auf die Magensekretion. 76. Tagg Dtsch. Ges. Inn. Med., April 1970.
Dotevall, G., Kock, N. G., Walan, A.: Inhibition of pentagastrin-induced gastric acid secretion in man by glucagon given intravenously. Scand. J. Gastroent.4, 713 (1969).
Gillespie, I. E., Grossman, M. I.: Inhibitory effect of secretin and cholecystokinin on Heidenhain pouch responses to gastrin extract and histamine. Gut5, 342 (1964).
Grossman, M. I.: Treatment of duodenal ulcer with secretin: a speculative proposal. Gastroenterology50, 912 (1966).
Kock, N. G., Darle, N., Dotevall, G.: Inhibition of intestinal motility in man by glucagon given intraportally. Gastroenterology53, 88 (1967).
La Barre, J., Castiau, J.: A propos des effects antiulcereaux de la secretine. 7th Congr. Intern. de l'Assoc. de Soc. Nat. Europ. et Meditérran. de Gastro-Entérologie, Bruxelles (1964), Abstr. p. 34.
Lin, T. M., Alphin, R. S.: Inhibition of gastric secretion by glucagon and glucose in the dog. Fed. Proc.17, 97 (1958).
—— Spray, G. F.: Effect of glucagon on gastric HCl-secretion. Gastroenterology54, 1254 (1968)—Abstr.
Ottenjann, R., Dehhle, P., Paul, F.: Über den Einfluß von Glukagon auf die gastrale Sekretion bei synchroner Calciuminfusion. Klin. Wschr.47, 724 (1969).
—— Paul, F., Deyhle, P.: Über den Einfluß intravenöser Phosphatpufferinfusion auf Serumcalcium und Magensekretion. Klin. Wschr.47, 723 (1969).
Paloyan, E., Paloyan, D., Harper, R. V.: Glucagon-induced hypocalcemia. Metabolism16, 35 (1967).
Paul, F., Deyhle, P., Ottenjann, R.: Über den Effekt von oralem Calcium und Magnesium auf die HCl-Sekretion des Magens. Münch. med. Wschr.12, 422 (1971).
Robinson, R. M., Harris, K., Hlad, C. D., Eiseman, B.: Effect of glucagon on gastric secretion. Proc. Soc. exp. Biol. (N.Y.)96, 518 (1957).
Scratcherd, T., Case, R. M.: The role of cyclic adenosine-3′5′-monophosphate (AMP) in gastro-intestinal secretion. Gut10, 957 (1969).
Solomon, S. P., Spiro, H. M.: The effect of glucagon and glucose on the human stomach. Amer. J. dig. Dis.4, 775 (1959).
Trudeau, W. L., McGuigan, J. E.: Effect of calcium on serum gastrin levels in the Zollinger-Ellison syndrome. New Engl. J. Med.281, 862 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paul, F., Deyhle, P. Langzeitwirkung von Glucagon auf die Magensekretion. Klin Wochenschr 49, 1229–1231 (1971). https://doi.org/10.1007/BF01732732
Issue Date:
DOI: https://doi.org/10.1007/BF01732732
Key-words
- Human gastric HCl-secretion
- reduction
- Glucagon
- long-term application
- possible therapeutic substance. Calciumcarbonate
- Serumcalcium
- Bloodsugar